Visioneering Technologies, Inc. (ASX:VTI)

Market Cap	n/a
Revenue (ttm)	12.95M +4.9%
Net Income	-5.21M
EPS	-0.11
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,658
Average Volume	34,401
Open	0.0660
Previous Close	0.0660
Day's Range	0.0660 - 0.0660
52-Week Range	0.0390 - 0.2700
Beta	1.87
RSI	47.83
Earnings Date	n/a

About Visioneering Technologies

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal 1-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 45
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: VTI

Financial Performance

In 2023, Visioneering Technologies's revenue was $8.67 million, an increase of 19.01% compared to the previous year's $7.29 million. Losses were -$3.45 million, -41.05% less than in 2022.

Financial numbers in USD